Literature DB >> 29954828

Comparative effectiveness of treatment options for plantar heel pain: a systematic review with network meta-analysis.

Opeyemi O Babatunde1, Amardeep Legha1,2, Chris Littlewood1, Linda S Chesterton1, Martin J Thomas1,3, Hylton B Menz1,4, Danielle van der Windt1,2, Edward Roddy1,3.   

Abstract

OBJECTIVE: To evaluate the comparative effectiveness of current treatment options for plantar heel pain (PHP).
DESIGN: Systematic review and network meta-analysis (NMA). DATA SOURCES: Medline, EMBASE, CINAHL, AMED, PEDro, Cochrane Database, Web of Science and WHO Clinical Trials Platform were searched from their inception until January 2018. STUDY SELECTION: Randomised controlled trials (RCTs) of adults with PHP investigating common treatments (ie, corticosteroid injection, non-steroidal anti-inflammatory drugs, therapeutic exercise, orthoses and/or extracorporeal shockwave therapy (ESWT)) compared with each other or a no treatment, placebo/sham control. DATA EXTRACTION AND ANALYSIS: Data were extracted and checked for accuracy and completeness by pairs of reviewers. Primary outcomes were pain and function. Comparative treatment effects were analysed by random effects NMA in the short term, medium term and long term. Relative ranking of treatments was assessed by surface under the cumulative ranking probabilities (0-100 scale).
RESULTS: Thirty-one RCTs (total n=2450 patients) were included. There was no evidence of inconsistency detected between direct and indirect treatment comparisons in the networks, but sparse data led to frequently wide CIs. Available evidence does not suggest that any of the commonly used treatments for the management of PHP are better than any other, although corticosteroid injections, alone or in combination with exercise, and ESWT were ranked most likely to be effective for the management of short-term, medium-term and long-term pain or function; placebo/sham/control appeared least likely to be effective; and exercise appeared to only be beneficial for long-term pain or function.
CONCLUSIONS: Current evidence is equivocal regarding which treatment is the most effective for the management of PHP. Given limited understanding of long-term effects, there is need for large, methodologically robust multicentre RCTs investigating and directly comparing commonly used treatments for the management of PHP. PROSPERO REGISTRATION NUMBER: CRD42016046963. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  foot; meta-analysis; primary care; review

Mesh:

Substances:

Year:  2018        PMID: 29954828     DOI: 10.1136/bjsports-2017-098998

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  17 in total

1.  Long-term effect and prognostic factors of a low-dose radiotherapy of painful plantar calcaneal spurs : A retrospective unicenter study.

Authors:  Volker Rudat; Nikoleta Tontcheva; Gudrun Kutz; Tina Ojevwe Orovwighose; Erich Gebhardt
Journal:  Strahlenther Onkol       Date:  2021-01-27       Impact factor: 3.621

2.  Corticosteroid injection for plantar heel pain: a systematic review and meta-analysis.

Authors:  Glen A Whittaker; Shannon E Munteanu; Hylton B Menz; Daniel R Bonanno; James M Gerrard; Karl B Landorf
Journal:  BMC Musculoskelet Disord       Date:  2019-08-17       Impact factor: 2.362

3.  Foot exercise plus education versus wait and see for the treatment of plantar heel pain (FEET trial): a protocol for a feasibility study.

Authors:  Melinda M Franettovich Smith; Natalie J Collins; Rebecca Mellor; Alison Grimaldi; James Elliott; Mark Hoggarth; Kenneth A Weber Ii; Bill Vicenzino
Journal:  J Foot Ankle Res       Date:  2020-05-08       Impact factor: 2.303

4.  Heavy-slow resistance training in addition to an ultrasound-guided corticosteroid injection for individuals with plantar fasciopathy: a feasibility study.

Authors:  Henrik Riel; Jens Lykkegaard Olesen; Martin Bach Jensen; Bill Vicenzino; Michael Skovdal Rathleff
Journal:  Pilot Feasibility Stud       Date:  2019-08-24

5.  Stretching and relaxing the plantar fascia may change plantar fascia thickness but not pressure pain thresholds: a cross-sectional study of patients with plantar fasciopathy.

Authors:  Stefanie Ostermann; Jens Lykkegaard Olesen; Sinéad Holden; Henrik Riel
Journal:  BMC Musculoskelet Disord       Date:  2020-12-03       Impact factor: 2.362

6.  Self-management advice, exercise and foot orthoses for plantar heel pain: the TREADON pilot and feasibility randomised trial.

Authors:  Linda S Chesterton; Martin J Thomas; Gordon Hendry; Ying Chen; David Goddin; Nicola Halliday; Sarah A Lawton; Martyn Lewis; Christian D Mallen; Hylton B Menz; Nadine E Foster; Edward Roddy
Journal:  Pilot Feasibility Stud       Date:  2021-04-01

7.  Online questionnaire, clinical and biomechanical measurements for outcome prediction of plantar heel pain: feasibility for a cohort study.

Authors:  Halime Gulle; Trevor Prior; Stuart Miller; Aleksandra V Birn-Jeffery; Dylan Morrissey
Journal:  J Foot Ankle Res       Date:  2021-04-26       Impact factor: 2.303

8.  Lived experience and attitudes of people with plantar heel pain: a qualitative exploration.

Authors:  Matthew Cotchett; Michael Skovdal Rathleff; Matthew Dilnot; Karl B Landorf; Dylan Morrissey; Christian Barton
Journal:  J Foot Ankle Res       Date:  2020-03-06       Impact factor: 2.303

9.  Effectiveness of physical therapy treatment in addition to usual podiatry management of plantar heel pain: a randomized clinical trial.

Authors:  Shane M McClinton; Bryan C Heiderscheit; Thomas G McPoil; Timothy W Flynn
Journal:  BMC Musculoskelet Disord       Date:  2019-12-28       Impact factor: 2.362

10.  Corticosteroid injection plus exercise versus exercise, beyond advice and a heel cup for patients with plantar fasciopathy: protocol for a randomised clinical superiority trial (the FIX-Heel trial).

Authors:  Henrik Riel; Bill Vicenzino; Jens Lykkegaard Olesen; Martin Bach Jensen; Lars Holger Ehlers; Michael Skovdal Rathleff
Journal:  Trials       Date:  2020-01-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.